Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 65   

Articles published

JNJ 105.06 +0.47 (0.45%)
price chart
Johnson & Johnson's McNeil unit receives criticism from FDA on quality control ...
Federal drug regulators are criticizing Johnson & Johnson's consumer product division's quality control procedures again after inspectors uncovered a number of violations, including the company's failure to adequately review more than 60 medical ...
Johnson & Johnson Remains Too Big to Succeed
NEW YORK ( TheStreet) -- Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck (MRK), Pfizer (PFE) and Abbott Laboratories (ABT) have delivered healthy returns over the years.
Related articles »  
Stocks for the Long Run: Johnson & Johnson vs. the S&P 500
Since 1995, Johnson & Johnson's earnings per share have grown by an average of 8.9% a year, compared with 6% a year for the broader index.
Related articles »  
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal ...
GUANGZHOU, China, May 3, 2012 /PRNewswire-Asia/ -- Johnson & Johnson (China) Investment Ltd. today announced it has acquired Guangzhou Bioseal Biotechnology Co.
3 Dow Stocks Up in a Down Market  Wall St. Cheat Sheet
Related articles »  
3 Reasons To Buy Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) shares have pulled back with the markets and now can be bought near the 52-week lows. This company is a diversified medical device, drug, and healthcare company that investors should consider now.
Related articles »  
Why Johnson & Johnson Looks Better Than Its Competitors
There have been several changes for Johnson & Johnson (NYSE:JNJ) recently, but the question for investors is whether or not these changes are for the better.
Related articles »  
Johnson & Johnson Vs. Medtronic: Healthcare Dividend Growth Analysis
Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) are two large American companies with long and storied histories in the healthcare industry.
Related articles »  
Johnson & Johnson Could Leap $4 Higher By 2013
Johnson & Johnson (NYSE:JNJ) is probably the most diversified of the large healthcare companies. In addition to a global consumer products business, Johnson & Johnson manufacturers and sells pharmaceutical and medical devices. Foreign sales ...
Related articles »  
Hankin makes old Johnson & Johnson space an incubator
EXTON - When Johnson & Johnson did not renew its lease for its freestanding building in Chester County, the property owner had a choice to make.
Imodium recalled by Johnson & Johnson's McNeil Consumer Healthcare
The latest recall continues a troubling trend for the Johnson & Johnson division, which has its headquarters in Montgomery County, and has had dozens of recalls in the last few years.
Related articles »